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Discovery of CD1 antigen presentation path-
ways shows how  T cells can specifically re-
spond to self- and foreign lipid components of 
cells. Whereas most CD1 research focuses on 
CD1d and NKT cells, there are four types of 
CD1 antigen-presenting molecules, which are 
each broadly conserved in mammalian evolution 
(Kasmar et al., 2009). Recent data make clear 
that CD1a, CD1b, CD1c, and CD1d do not 
have redundant functions but instead have clearly 
differing patterns of tissue expression, distinctly 
shaped antigen binding grooves, diverse path-
ways of intracellular trafficking, and trigger dif-
fering effector functions of responding T cells 
(Young and Gapin, 2011). CD1c proteins are 
distinguished from other CD1 proteins by their 
constitutive expression at high density on the sur-
face of marginal zone or activated B cells (Weller 
et al., 2004; Roura-Mir et al., 2005a; Allan et al., 
2011) and subsets of DCs (Dzionek et al., 2000). 
Unlike CD1d, which is constitutively expressed 
on monocyte-derived DCs (MDDCs), CD1c is 
inducibly expressed on MDDCs after cytokine 
exposure (Porcelli et al., 1989; Yakimchuk et al., 
2011). Thus, CD1c proteins have been proposed 
to mediate interactions of T cells with B cells 
and DCs as two major populations of APCs.
Despite extensive knowledge of CD1c pro-
tein trafficking in cells, the antigen-presenting 
function and antigens for the CD1c system 
are poorly understood. After translation, CD1c 
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CD1c is expressed with high density on human dendritic cells (DCs) and B cells, yet its anti-
gen presentation functions are the least well understood among CD1 family members. Using 
a CD1c-reactive T cell line (DN6) to complete an organism-wide survey of M. tuberculosis 
lipids, we identified C32 phosphomycoketide (PM) as a previously unknown molecule and a 
CD1c-presented antigen. CD1c binding and presentation of mycoketide antigens absolutely 
required the unusual, mycobacteria-specific lipid branching patterns introduced by polyketide 
synthase 12 (pks12). Unexpectedly, one TCR responded to diversely glycosylated and ungly-
cosylated forms of mycoketide when presented by DCs and B cells. Yet cell-free systems 
showed that recognition was mediated only by the deglycosylated phosphoantigen. These 
studies identify antigen processing of a natural bacterial antigen in the human CD1c system, 
indicating that cells act on glycolipids to generate a highly simplified neoepitope composed 
of a sugar-free phosphate anion. Using knowledge of this processed antigen, we generated 
human CD1c tetramers, and demonstrate that CD1c–PM complexes stain T cell receptors 
(TCRs), providing direct evidence for a ternary interaction among CD1c-lipid-TCR. Further-
more, PM-loaded CD1c tetramers detect fresh human T cells from peripheral blood, demon-
strating a polyclonal response to PM antigens in humans ex vivo.
© 2013 Ly et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
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are branched chain phospholipids: synthetic mannosyl phos-
phodolichols (MPDs) and mycobacterial mannosyl--1-phos-
phomycoketide (MPM; Moody et al., 2000; Matsunaga et al., 
2004). The latter is known to bind within the A pocket of 
the CD1c groove (Scharf et al., 2010). Patients infected with 
M. tuberculosis have CD1c-dependent polyclonal responses 
to MPD, providing direct evidence that expansion of phos-
pholipid-reactive T cells is part of the natural history of tu-
berculosis infection (Moody et al., 2000).
In this study, we sought to identify new antigens in 
the CD1c system and to develop CD1c tetramers as new 
tool for biological investigation. We used a CD1c-reactive 
T cell line (DN6) as a reporter to screen through all types of 
lipids in M. tuberculosis. This organism-wide screen for lipids, 
combined with genetic and synthetic chemistry approaches, 
identified a previously unknown molecule, C32 PM, as a 
CD1c-presented antigen. Using natural and synthetic ana-
logues of mycoketides, we determined that T cell activation 
by diverse glycolipids is mediated by cellular processing re-
actions in activated B cells and DCs, which release carbohy-
drate head groups and reveal a simplified epitope derived 
from structurally diverse precursors. After identifying the 
molecular features of PM epitopes needed to contact TCRs, 
proteins normally exit to the surface and then recycle through 
the secretory and endosomal pathways, based on their cyto-
plasmic tails binding to AP2 (adaptor protein 2; Briken et al., 
2000; Sugita et al., 2000). This interaction mediates traffick-
ing to diverse compartments, including recycling endosomes 
with neutral pH and highly degradative lysosomes (Sugita 
et al., 2000). CD1c’s broad distribution throughout diverse 
endosomal compartments seems to be linked to its antigen-
presenting function. For example, low pH promotes recog-
nition of some antigens (Briken et al., 2000; Sugita et al., 2000) 
but leads to destruction of other antigens (Van Rhijn et al., 
2009). Mass spectrometry studies of small molecules released 
from recombinant CD1c proteins detect highly diverse en-
dogenous amphipathic glycolipids, including phospholipids 
(Haig et al., 2011; Huang et al., 2011). CD1c proteins are pro-
posed to function in host response to infection because they 
are transcriptionally up-regulated in response to Toll-like re-
ceptor 2 agonists found in Mycobacterium tuberculosis and Borrelia 
burgdorferi, using a mechanism that involves IL-1 release at 
the site of infection (Roura-Mir et al., 2005b; Yakimchuk 
et al., 2011). Yet, in contrast to the extensive knowledge of 
the many glycolipid antigens presented by CD1d and CD1b 
proteins, the only known natural antigens specific for CD1c 
Figure 1. Isolation and identification of 
PMs. IL-2 production from the DN6 T cell line 
co-cultured with C1R expressing CD1a, CD1b, 
CD1c, or CD1d (A) or MDDC (B) in the pres-
ence of lipid extracts from the indicated bac-
teria. (C) Water-visualized bands extracted 
from silica plates screened for their capacity 
to stimulate DN6. IL-2 production from DN6 
co-cultured with MDDC in the presence of 
titrating volume equivalents of TLC band  
extracts. (D) Mass spectra at retention time  
6–8 min displaying mass window containing 
C32-PM (m/z 545.47) within TLC band 4 com-
pared with synthetic C32-PM and CID-MS 
collision products. Bioactive IL-2 production 
as measured by HT-2 proliferation from DN6 
co-cultured with MDDC in the presence of 
synthetic C32-PM. Data are mean ± SD of 
triplicate measurements representative of  
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solvents to recover total extractable lipids. We separated these 
lipids into subclasses using silica columns sequentially eluted with 
chloroform, acetone, and methanol, which enrich for neutral 
lipids, glycolipids, and phospholipids, respectively (Fig. 1 C).
After T cell testing showed selective response to the meth-
anol eluate, these polar lipids were further resolved in the 
normal phase by preparative TLC. Using nondestructive vi-
sualization with water spray, 10 bands of lipid-laden silica were 
scraped, extracted, and screened for stimulatory capacity. The 
visualized bands were numbered so that higher numbers cor-
respond to higher retention factors (Rf). We found that DN6 
was activated in a dose-dependent activation by bands 3 and 4, 
with the highest titer noted for band 4 (Fig. 1 C). To chemi-
cally identify the antigen, we further studied band 4 through 
separation into subfractions using HPLC–mass spectrometry 
(HPLC-MS). Mass spectrometry revealed an ion at m/z 
545.469 that was consistently present in antigenic subfrac-
tions of band 4.
we generated working CD1c tetramers loaded with PM, which 
identified polyclonal PM-specific T cells in ex vivo analysis of 
human blood.
RESULTS
Discovery of PMs in M. tuberculosis
The CD4CD8 T cell line DN6 (Beckman et al., 1996) 
represented a highly useful reporter line to detect new kinds 
of CD1c-presented antigens because its activation was entirely 
dependent on, and specific for, CD1c (Fig. 1 A). Further-
more, we reasoned that this clone might detect a natural an-
tigen that is produced during mycobacterial infection because 
DN6 was specifically activated by lipid extracts of medically 
important mycobacteria, like M. tuberculosis and Mycobacterium 
avium, but not soil-dwelling mycobacteria or other bacteria such 
as Rhododoccus equi, Nocardia farcinica, or Escherichia coli (Fig. 1 B). 
To isolate the antigens recognized by DN6, we subjected 
M. tuberculosis to extraction with chloroform and methanol 
Figure 2. Promiscuous recognition of 
PMs. (A) A proposed biosynthetic pathway of 
mycoketide lipids derives from studies of 
Pks12 and Ppm1 gene products and direct 
isolation of PM from M. tuberculosis. (B) IL-2 
production from DN6 and CD8-1 T cell line 
co-cultured with MDDC in the presence of 
volume equivalents of HPLC subfractions 
screened over a 3-log titration. Reported are 
the activity at dosehalf-maximal for DN6 (1/5 
volume equivalent) and CD8-1 (1/80 volume 
equivalent) normalized to the highest active 
band 3 subfraction. Data are representative 
singlicate measurements from two separate 
experiments. (C) Chromatogram identified 
lipids extracted present in TLC band 3 (left) 
and IL-2 production from DN6 co-cultured 
with MDDC in the presence of fatty acid 
chain phospholipids or lyso forms, phospho-
lipid phosphatidic acid (PA), phosphatidyl-
inositol (PI), phosphatidylglycerol (PG), 
phosphatidylserine (PS), or C19:0/C16:0 PE 
(tuberculostearic acid PE; (right). (D) IL-2 
production from DN6 co-cultured with 
MDDC in the presence of total lipid extracts 
from parental, pks12-deficient, and comple-
mented mycobacterial strains. Data are mean ± 
SD of triplicate measurements representative 
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which shows elution profiles detected at masses correspond-
ing to common phospholipids (Layre et al., 2011), identified 
at least six named anionic phospholipids in fractions 3 and 4 
(Fig. 2 C and not depicted). These lipids included lyso-phos-
phatidylethanolamine or lyso-phosphatidylinositol dimanno-
side (PIM2), which are similar or identical to known CD1d- or 
CD1b-presented antigens (de la Salle et al., 2005; Fox et al., 
2009; Zeissig et al., 2012). Therefore, we tested DN6 response 
to purified lyso-phospholipids and phospholipids matching 
those detected in bands 3 and 4, as well as other structurally 
related molecules. The lack of response to all tested phospho-
lipids ruled out extreme promiscuity (Fig. 2 C, right).
DN6 might still recognize lipids that were missing from 
the panel of tested phospholipids or represent some nonmyco-
ketide that could not be detected by LC-MS in M. tuberculosis. 
Therefore, we tested DN6 response to M. tuberculosis that is se-
lectively deficient in all mycoketides as the result of an engi-
neered deletion in the enzyme that produces mycoketides, pks12, 
of strain H37Rv. Total lipids from the strains (H37Rvpks12) 
or the equivalent deletion in M. tuberculosis strain 1551 or 
BCG failed to activate DN6 (Fig. 2 D). Yet DN6 did recognize 
lipids from wild-type and genetically complemented strains at 
titers expected based on levels of Pks12 complementation. 
These genetic experiments ruled out cross-recognition of dif-
fering lipid anchors, proving that core mycoketide backbone 
is necessary for the T cell response.
The molecular basis of mycoketide recognition
Next we tested whether the broad response profiles (Fig. 2 B) 
might result from cross-reactivity of DN6 to differentially 
modified mycoketides in the biosynthetic pathway (Fig. 2 A). 
Because structure-function studies of bacterial sources can 
be confounded by traces of nearly coeluting natural mole-
cules, we synthesized pure, all-synthetic (S) mycoketides with 
free alcohol, phosphate, and - or -1–linked phospho-
mannose groups (Fig. 3 A). Whereas the CD8-1 T cell line 
was highly specific for -mannosylated mycoketides (Moody 
et al., 2000), DN6 responded promiscuously to unglycosyl-
ated and -mannosylated analogues (Fig. 3 A). The cross-
reactivity of DN6 for PM and MPM likely explained the 
broad response profile of DN6 to mycobacterial lipid sub-
fractions because PM was present in band 4 and MPM in 
band 3 (Fig. 1 D; and Fig. 2, B and C). Synthetic molecules 
provided further insights into the pattern of DN6 T cell re-
sponse, including an absolute requirement for a phosphate 
moiety. Surprisingly, DN6 showed cross-reactivity for the 
nonnatural analogue in which mannose is carried in the 
-anomeric linkage (Fig. 3 A). These patterns of reactivity, 
seen with synthetic all-S mycoketide analogues (Fig. 3 A), 
were further tested with differentially phosphorylated or gly-
cosylated molecules coupled to sterorandom mycoketide 
or dolichol backbones (Fig. 3, B and C). Among all analogues, 
we observed a consistent pattern of recognition in that the 
phosphate was absolutely required, but only DN6 promis-
cuously recognized glycosylated or unglycosylated ana-
logues (Fig. 3, B and C).
This candidate antigen was named Ag545 based on its nomi-
nal mass. The accurate mass of Ag545 matched C32H66O4P 
within 1 ppm, and no other chemical formula matched within 
the mass accuracy of the QTof (quadrupole time of flight) mass 
detector. We could not identify any known molecule with this 
chemical composition in the literature or recently compiled 
databases of M. tuberculosis lipids (Layre et al., 2011; Sartain 
et al., 2011). Collision-induced dissociation mass spectrometry 
(CID-MS) identified a fragment corresponding to phosphate, 
m/z 78.959 (expected m/z, 78.9585), with neutral loss of 
466.512 (Fig. 1 D). This pattern allowed assignment of Ag545 
as a fully saturated C32 alkylphosphate. The C32 length was 
notable because it is unusual for fatty acids and other com-
mon alkane lipids but did match the length of C32 mannosyl 
-1 PM (MPM), a previously known CD1c-presented antigen 
(Matsunaga et al., 2004).
Synthesis of antigenic PMs
Based on an apparent structural analogy, we hypothesized 
that Ag545 was C32 PM, which lacked the mannosyl unit 
seen in MPM (Fig. 2 A). Because Ag545 was produced only 
in trace amounts and resistant to extensive collision-induced 
dissociation (Fig. 1 D), the precise structure of its lipid moi-
ety could not be solved by mass spectrometry. However, 
based on the assumption that the known mannosyl PM and 
Ag545 share the same C32 lipid moiety with five repeating 
branches in the S-configuration (C32 all-S; de Jong et al., 
2007), we used stereospecific condensation methods (van 
Summeren et al., 2006) to synthesize C32 all-S PM. This 
product matched the retention time and CID-MS pattern as 
Ag545 from band 4, and it potently stimulated DN6 at nano-
molar concentrations (Fig. 1 D and not depicted). These stud-
ies identified C32 PM as a previously unknown molecule in 
M. tuberculosis and as a CD1c-presented antigen.
DN6 promiscuously recognizes phospholipids
These data proved that C32 all-S mycoketides are presented 
by CD1c to T cells, but two aspects of the antigen discovery 
effort suggested that DN6 responds promiscuously to other 
mycobacterial phospholipids. First, testing of DN6 to all HPLC 
subfractions (designated X.Y, where X is the TLC band and Y 
is the HPLC subfraction) demonstrated a response profile to 
fractions 3.7 to 3.13 and 4.9 through 4.14, which was a much 
broader response profile observed when comparing with other 
T cell lines, including CD8-1 (Fig. 2 B). Second, T cell re-
sponses to bacterial MPM, glucose monomycolate, diacylated 
sulfoglycolipids, dideoxymycobactins, and other antigens are 
typically specific for the structure of the large, carbohydrate-
containing headgroups (Beckman et al., 1994; Moody et al., 
1997; Gilleron et al., 2004; Moody et al., 2004; de Jong et al., 
2007). Yet the PM antigen has a highly simplified head group, 
which lacks a carbohydrate and contains only a primary phos-
phoalcohol anion (Fig. 1 D). The simplified headgroup structure 
and broad response profiles suggested that DN6 promiscuity 
might take an extreme form, possibly recognizing any anionic 
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an isoelectric focusing (IEF) shift, when all methyl branches 
were present (Fig. 3 D, inset). Although the shift was small in 
magnitude, it was reproducible and similar in magnitude to 
that seen in prior studies of crystallized CD1c-MPM com-
plexes (Scharf et al., 2010). Thus, the S-methyl branches, 
which are defining for mycoketides, are required for binding 
to CD1c and activation of T cells.
CD1c presents two antigens in the mycoketide pathway
The structural homology of PM and MPM suggested a possi-
ble precursor-product relationship (Fig. 2 A). Pks12 (polyketide 
synthase 12) and Ppm1 (polyprenol monophosphomannose 
synthase) are two linked genes encoding enzymes with the 
catalytic domains needed to condense malonyl and methyl 
malonyl units and to transfer a mannosyl unit, respectively 
(Gurcha et al., 2002; Matsunaga et al., 2004). Thus, identifi-
cation of PM clarifies the mechanism of MPM biosynthesis 
Considering the biological origins of lipids, mycoketides 
are highly unusual structures that differ from common mam-
malian straight chain lipids based on their size (C32), length 
(C27), and five methyl branches in the (S) stereoconfigura-
tion. To directly test the requirement of T cell specificity for 
the branches that characterize the mycoketide lipid moiety, 
we tested DN6 response to MPM produced in a form that are 
shorter in length or in which the (S) methyl branches were 
missing or converted to (R) stereochemistry (van Summeren 
et al., 2006; de Jong et al., 2007). The analogues lacking some 
or all of the methyl branches begin to mimic straight chain 
lipids. DN6 showed a 100-fold reduction in dose response 
when one out of five methyl branches were present in the 
S-configuration. We did not detect any stimulation from an-
alogues with one methyl branch in the R-configuration, or with 
no methyl branches, or with a shortened lipid (Fig. 3 D). 
Furthermore, CD1c–lipid complexes were formed and induce 
Figure 3. Mycoketide anchors are  
necessary for T cell activation. (A–C) IL-2 
production from DN6 and CD8-1 T cells co-
cultured with MDDC was measured in the 
presence of synthetic C32 (all-S) mycoketide 
analogues, or (B) synthetic C30 (racemic) 
mycoketides or (C) synthetic C35 phospho-
dolichols. (D) IL-2 production from DN6  
co-cultured with MDDC in the presence of 
synthetic alkyl branch modified C32-mannosyl-
PMs and (inset) native isoelectric focusing gel 
shift of CD1c loaded at fivefold molar excess 
alkyl branch modified mycoketides. Data are 
mean ± SD of triplicate measurements repre-
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Antigen processing of CD1c presented lipids
Based on a recent crystal structure of CD1c with MPM 
(Scharf et al., 2010), complexes formed with glycolipids of 
differing - or -anomeric linkage would position the man-
nose at markedly different positions on the outer surface 
of CD1c, or, alternatively, strain the bond at C1 on man-
nose. In one well studied example, NKT cells recognize both 
- and -linked hexosyl ceramides, but the linkage influences 
potency by >100-fold as a result of carbohydrate positioning 
and C1 bond strain (Brennan et al., 2011; Pellicci et al., 
2011). In other examples, the linkage of the proximal car-
bohydrate is an all-or-nothing determinant of recognition 
(Kawano et al., 1997; Moody et al., 1997, 2000). Therefore, 
it would be surprising if mycoketide epitopes formed with 
- linked, -linked, or no carbohydrate were recognized with 
equal potency (Fig. 3). We considered the possibility that 
diverse glycophosphospholipid analogues were processed by 
APCs to create one core epitope so that the same epitope was 
formed with three different input molecules. APCs trim syn-
thetic or natural glycolipids for presentation by CD1b and 
CD1d (Prigozy et al., 2001; Zhou et al., 2004; de la Salle et al., 
2005). However, whether bacterial glycolipids are frequently 
(Fig. 2 A). Together with a prior study (Moody et al., 2000), 
we conclude that CD1c presents two distinct products in 
the mycoketide biosynthetic pathway (Fig. 2 A).
Cross-reactivity of DN6 to mycoketides with hydrophilic 
head groups composed of phosphate alone, -mannosyl, or 
-mannosyl units was surprising and remained unexplained. 
The DN6 line might contain several clonal populations with 
distinct TCRs that separately recognize each PM analogue, 
or the T cell line might be activated by TCR-independent 
means, similar to lipopolysaccharide activation of NKT 
cells (Brigl et al., 2003). Using DN6 cultures, we amplified 
TCR- and - chain sequences using a diverse TCR primer 
set based on the international ImMunoGeneTics (IMGT) 
database and detected several minor bands and two domi-
nant bands corresponding to one TCR- (TRAV36/DV7) 
and one - chain (TRBV6-6). After cloning, we cotrans-
fected these chains into the T lymphoblastoid cell line Hut78 
(Fig. 4 A). Whereas untransfected Hut78 with an endoge-
nous TCR showed no reactivity, the DN6 TCR transfec-
tant was activated by PM, -MPM, and -MPM. Therefore, 
DN6 response was mediated by one  TCR that promis-
cuously recognizes three distinct forms of mycoketide.
Figure 4. Antigen processing of CD1c presented lipids. 
(A) IL-2 production from Hut78 cells transfected with DN6 
TCR was measured in response to mycoketides presented by 
K562 cells expressing CD1c or by APC-free plate-bound 
CD1c. (B) DN6 and CD8-1 activity toward PMs presented by 
plate-bound CD1c. (C) Surface expression of CD1c on B cells 
stimulated with anti-Ig antibody was measured (C, left) 
before assays measuring DN6 stimulation using synthetic 
C32 (all-S) mycoketides (C, right). Data are representative 
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Development of CD1c tetramers
Whereas initial efforts to detect polyclonal human T cells 
with CD1c tetramers loaded with MPM were unsuccessful, 
detailed knowledge of the processed epitopes recognized by 
the TCR offered a new approach to CD1c tetramer develop-
ment. Based on approaches used previously for MHC class I, 
CD1d, and CD1b (Altman et al., 1996; Matsuda et al., 2000; 
Karadimitris et al., 2001; Lee et al., 2002; Kasmar et al., 2011), 
we produced and validated human CD1c tetramers bound to 
C32 PM. Transmembrane truncated CD1c heavy chains were 
linked to -2 microglobulin using leucine zippers and bio-
tinylated using a BirA enzyme. Polyacrylamide gel electropho-
resis showed that CD1c–2m complexes migrated with the 
expected apparent molecular weight and showed high percent-
age of biotinylation in avidin pulldown experiments (Fig. 5 A). 
Also, IEF gel-shift assay of CD1c loaded with PM induced a 
subtle but visible shift of protein, demonstrating complex for-
mation (Fig. 5 B).
We favored a cognate model in which CD1c–antigen 
complexes might bind the DN6 TCR. However, alternative 
models show that certain bacterial lipids activate T cells indi-
rectly through induced cytokine secretion (Brigl et al., 2011) 
or through bacterially induced endogenous lipid production 
(De Libero et al., 2005; Brennan et al., 2011). Also, recent 
studies show that CD1 interacts with cell surface receptors 
other than TCR, such as Ig-like transcript (ILT; Li et al., 2009, 
2012). To distinguish among these models and attempt to detect 
the ternary complex, DN6 was stained with newly generated 
CD1c tetramers loaded with C32 PM. This line was com-
prised of 67% of cells that expressed the clonotypic TRBV6-6+ 
TCR and 33% of cells with other TCRs, providing a negative 
control for staining (Fig. 5 C). PM-loaded but not unloaded 
or rarely altered before TCR recognition was unknown, and 
antigen processing had not been previously reported for the 
CD1c system. Conversion of - and -linked MPM to PM 
product in cells was plausible based on CD1c’s broad traffick-
ing throughout the endosomal network, including lysosomes 
(Briken et al., 2000; Sugita et al., 2000).
We tested this model by removing all cellular process-
ing factors and compared responses of native T cells to PM, 
-MPM, and -MPM presented by recombinant CD1c pro-
teins affixed to a plate. In contrast to cells, which present all 
three antigens, recombinant CD1c presents only the core PM 
epitope to the native DN6 line (Fig. 4 B) and HUT cells ex-
pressing the DN6 TCR (Fig. 4 A). Strong CD8-1 activation 
at low doses indicated that -MPM–CD1c complexes were 
formed under these conditions. Thus, presentation of - and 
-linked forms requires cellular processing, and the -mannose 
unit is neither required nor permissive for activation of DN6. 
Whereas initial experiments were performed in K562 tumor 
cells, the same pattern of recognition was seen when pre-
sented by myeloid DCs (Fig. 3) and activated human B cells 
(Fig. 4 C). These studies confirm a recent study reporting 
that CD1c expression and function on human B cells is pro-
moted by cellular activation (Fig. 4 C; Allan et al., 2011). 
More generally, these findings indicate that antigen process-
ing occurs efficiently in native human cells that normally 
express CD1c and strongly support a model in which - and 
-linked mannose units are removed by APCs so that TCRs 
contact simple sugar-free phosphate epitope. Binding of TCRs 
to CD1c had not been previously reported, but development 
of CD1c tetramers loaded with PM antigens provides a direct 
test for the key prediction of this model: the deglycosylated 
epitope might mediate binding of CD1c to a TCR.
Figure 5. C32-PM–loaded CD1c tetramers demonstrate 
ternary CD1c–TCR interactions. (A) Page gel demonstrates 
the purity and apparent mass of CD1c: 2M monomers.  
(B) Native isoelectric focusing gel analysis shows a shift of 
CD1c loaded complexes at 5 or 20 molar excess C32-PM.  
(C) C32-PM–loaded CD1c tetramer stains the polyclonal DN6 
cell line, which includes a subpopulation of TRBV6-6 TCRs 
that mediates reactivity to PM. Values within plots indicate 
percent of all cells within gates and quadrants. (D) C32- 
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mycoketides, when presented by APCs, consistent with recog-
nition of epitopes processed by deglycosylation (Fig. 6 E). We 
conclude that C32-PM responsive T cells are present in vivo 
and that conversion of MPM to yield PM is a generalizable 
antigen processing recognized by diverse human T cell clones.
DISCUSSION
Here we report the second known natural foreign antigen in 
the CD1c system as a C32 (all-S) PM. This molecule likely 
functions as the biochemical precursor of the only other 
known bacterial antigen for CD1c, mannosyl--1-PM (Moody 
et al., 2000). It is notable that both PM and MPM were both 
unknown molecules until discovered through unbiased bacte-
rium-wide surveys of many hundreds of lipid types using CD1c-
restricted T cells as probes. Based on the global nature of the 
screens used, the detection of two antigens in the same path-
way with the same lipid anchor suggests a specialized role of 
the CD1c groove in mycoketide capture. Contrasting with 
the more abundant phospholipids comprised of straight alkyl 
chains that are common in both mycobacterial and mammalian 
cells, mycoketides contain five alkyl branches with S configu-
ration, which can be considered a pathogen-specific molecu-
lar pattern. A recent crystal structure of MPM bound to CD1c 
provides a specific model of how the methyl branches in the 
mycoketide backbone promote binding (Scharf et al., 2010). 
The C32 mycoketide lipid enters and fully occupies the A 
pocket, which is a toroid cavity buried under the A roof. The 
branched mycoketide moiety is positioned like a spiral stair-
case such that the linear backbone carbons occupy the smaller 
inner surface of the toroid and the methyl branches fan out to 
occupy the larger, outer diameter of the pocket. Here we show 
that these foreign branches, which are characteristic of myco-
ketides and absent from common unbranched self-lipids, are 
the molecular feature needed for binding to CD1c. Further-
more, no lipid produced independently of Pks12 can substi-
tute in generating this CD1c-mediated T cell response. Overall, 
independent detection of two mycoketides as CD1c-presented 
antigens, the hand-in-glove fit of the mycoketide to the A 
pocket of CD1c, and direct evidence for class-defining methyl 
branches in CD1c binding suggest that mycoketides represent a 
natural foreign, optimized lipid anchor for CD1c. Although 
no single antigen would be expected to occupy all CD1c pro-
teins in a cell, these data point to repeating methyl branches as 
a mechanism for efficient capture of antigens produced at low 
levels from among the much larger pool of self-lipids.
In cell-free assays, T cell clones do not cross-react between 
PM and MPM, so the two molecules are separate and valid anti-
gens recognized by distinct TCRs within the CD1c system. 
Yet activated B cells and MDDCs present MPM to PM-specific 
TCRs, providing evidence for antigen processing to create a 
neoepitope formed from a simple phosphate anion. PM and 
MPM are likely in the middle and end of the MPM biosyn-
thetic pathway, respectively, and only end products of pathways 
typically accumulate. Supporting this prediction, lipidomic de-
tection of MPM signal occurs at higher intensity than PM, 
which is just above the limits of detection of sensitive mass 
tetramers brightly stained cells expressing TRBV6-6. Further-
more, lack of staining of TRBV6-6 cells (Fig. 5 C) and the 
lack of staining of T cells with unloaded tetramers provided 
evidence that the interaction requires antigen and is specific 
for TCR structure. Furthermore, we observed PM-dependent 
staining of the TCR-transfected, but not untransfected, SupT1 
cells, proving that the  TCR is the sole ligand sufficient for 
mediating binding of CD1c–PM complexes on the cell sur-
face (Fig. 5 D). We conclude that CD1c binds specifically to 
the clonotypic DN6 TCR in a ternary interaction mediated 
by the PM antigen.
CD1c tetramers detect PM-reactive T cells ex vivo
Production of working tetramers of human CD1c has been 
a longstanding but unrealized goal in the field. Prior stud-
ies showed that MPD added to human DCs causes CD1c-
dependent proliferation of T cells in latent tuberculosis patients 
at higher numbers as compared with uninfected control patients 
(Moody et al., 2000). Such activation assays provide evidence 
for CD1c and phospholipid-mediated expansion of T cells dur-
ing natural tuberculosis infection. CD1c tetramers directly bind 
to the TCR in ways that rule out potentially confounding re-
sults common to all activation assays, including indirect T cell 
activation by bacterial products and T cell activation by non–
T cells. Also, only tetramers allow direct determination of the 
epitope recognized when unprocessed antigens are added to 
DCs or other APCs. Therefore loading CD1c tetramers with 
PM offered an opportunity for direct biophysical detection of 
fresh CD1c-restricted T cells in humans and mapping of can-
didate PM epitopes from MPM lipids.
Polyclonal T cells from PBMC of donors with latent 
M. tuberculosis were stained with PM-loaded CD1c tetramers. 
PM-loaded but not unloaded CD1c tetramers stain T cells 
(Fig. 6 A). This result potentially provided proof for CD1c and 
lipid-reactive cells ex vivo based on biophysical interactions, 
but it remained formally possible that CD1c was binding to 
ligands like ILT4 rather than  TCRs (Li et al., 2012). Thus, 
PM-loaded CD1c tetramer stained cells were sorted and ex-
panded and cloned. With this method, we could consistently 
generate cell lines from all donors tested that stained with 
C32-PM loaded but not unloaded CD1c tetramer (Fig. 6). 
Generated lines were initially screened for binding of C32-PM 
loaded tetramer and then screened for antigen reactivity 
(Fig. 6 A). All eight newly derived T cell lines were activated by 
APCs only in the presence of CD1c and antigen, as expected 
from a TCR-mediated response (Fig. 6). Furthermore, poly-
clonally expanded lines and T cell lines derived from limiting 
dilution cloning remained responsive to C32-PM even after 
repeated expansion in culture (Fig. 6, C and D). DN6 and 
CD8-1 are CD4CD8 and CD8+ clones, respectively, and 
were derived using earlier methods that started with CD4 T 
cells to avoid alloreactivity (Porcelli et al., 1989). All CD1c-
reactive lines derived here, using an unbiased approach based 
on CD1c tetramers, are CD4+ (Fig. 6). Finally, newly derived 
T cell lines captured based on their TCRs binding to C32 











Published March 25, 2013
JEM Vol. 210, No. 4 
Article
737
Figure 6. Ex vivo detection of C32-PM–reactive T cells 
with lipid-loaded CD1c tetramers. (A) T cell–enriched staining 
of PBMC with C32-PM–loaded CD1c tetramers ex vivo shows 
frequency of gated population among CD3+ cells. (B) A short-term 
T cell line derived from tetramer-positive sorting was screened 
for C32-PM–loaded CD1c tetramer staining and IFN- release 
upon stimulation with C32-PM presented by CD1-expressing 
APC. (C and D) Polyclonal T cells (C) and T cell lines generated by 
limiting dilution cloning (D) maintain recognition of C32-PM 
after repeated expansions when tested at 30 or 80 d after deriva-
tion. (E) IFN- release by T cell clones stimulated with C32-PM and 
C32-MPM presented by CD1-expressing APC was measured. In all 
cases, cell lines were screened for antigen reactivity two or more 
times, except for donor 1 cell line 22 and donor 3 cell line 30 which 
failed to propagate long-term after the assays shown here. Data 
are representative mean ± SD of triplicate measurements.
spectrometry detectors. Only MPM is detected as a secreted 
lipid in M. tuberculosis conditioned media (Matsunaga et al., 
2004; and unpublished data). These findings point to a model 
in which PM is rapidly turned over by Ppm1 during the gen-
eration of MPM so that only MPM is produced at higher 
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from H. Band (Northwestern University). M. tuberculosis CDC1551 and 
Mycobacterium smegmatis 607 was obtained from the Centers for Disease Con-
trol and Prevention. M. bovis BCG, Mycobacterium phlei, Mycobacterium fallax, 
Rhodocccus equi, and Nocardia farcinica were obtained from the American Type 
Culture Collection. M. tb H37Rv pks12, M. tb H37Rv pks12::pks12, 
M.tb CDC1551 pks12, and M. bovis BCG pks12 were generated as previ-
ously described (Matsunaga et al., 2004). M. tuberculosis H37Rv were maintained 
on Middlebrook 7H10 plates supplemented with oleic acid–albumin–dextrose 
complex. For liquid culture, a single colony was inoculated in Middlebrook 
7H9 media with 0.2% glycerol supplemented with 10% albumin–dex-
trose and grown to mid-log phase. M. phlei, M. fallax, Rhodocccus equi, and 
Nocardia farcinica were grown as previously described (Moody et al., 2002).
Lipid extraction, chromatography, and synthesis. Bacteria harvested 
near mid-log phase were extracted at 5 mg/ml in chloroform/methanol (C/M; 
2:1, vol/vol) for 1 h at room temperature followed by centrifugation and 
removal of supernatants. The pellet was reextracted in C/M (1:1, vol/vol) 
and C/M (1:2, vol/vol), and all three supernatants were pooled to give total 
lipids. Total lipids (50 mg) were applied to a silica gel column (23 ml of 
bed volume; Alltech), equilibrated with chloroform, and washed with 40 ml 
chloroform, 40 ml acetone, and 50 ml methanol. The methanol eluate was 
further purified by TLC using silica gel G plates (Analtech Inc.) with a sol-
vent system of chloroform/methanol/water (60:30:6, vol/vol/vol). After vi-
sualization with water spray, 10 bands were scraped and extracted from the 
silica gel with chloroform/methanol (1:2, vol/vol) and stored at 20°C. 
Synthesis of C32 PM, C30 mannosyl -PM, C35 MPD, C35 phospho-
dolichol, all-S  and  anomeric C32 mannosyl PM, and C19:0/C16:0 
phosphatidylethanolamine (TBSA) were accomplished previously or with 
new methods based on those from prior studies (Moody et al., 2000; van 
Summeren et al., 2006; Ter Horst et al., 2010). Synthetic preparations of 
the following lipids were commercially obtained (Avanti Polar Lipids): C18:1/
C18:0 phosphatidic acid, C18:0/C18:1 phosphatidylglycerol, C16:0/C16:0 
phosphatidylinositol, C18:0/C18:1 phosphatidylserine, C18:1 lyso-phospha-
tidic acid, C18:0 lyso-phosphatidylglycerol, C18:0 lyso-phosphatidylinositol, 
C18:0 lyso-phosphatidylserine, and C26:0 lyso-phosphatidylcholine. All lip-
ids were dissolved in chloroform/methanol 1:1 and stored at 20°C. Before 
use, stock lipids were brought to room temperature and aliquots were dried 
under gas nitrogen and resuspended in culture media or PBS for sonication 
in water bath before use.
HPLC fractionation of thin layer chromatography extract. TLC 
bands 3 and 4 were subjected to separation by HPLC with a Monochrome 
Diol column (46 × 250 mm, 3 µm; Varian Inc.) and coupled online to a 
LCQ Advantage ion-trap mass spectrometer (ThermoElectron) equipped 
with an electrospray ionization (ESI) source. In brief, Mobile phase A con-
sisted of hexane/isopropanol (60:40, vol/vol) containing 0.1% (vol/vol) for-
mic acid, 0.05% (vol/vol) ammonium hydroxide, and 0.05% (vol/vol) 
triethylamine. Mobile phase B consisted of methanol containing 0.1% 
(vol/vol) formic acid, 0.05% (vol/vol) ammonium hydroxide, and 0.05% 
(vol/vol) triethylamine. A binary gradient was used with flow rate of 0.7 
ml/min and column temperature of 25°C starting at 5% mobile phase B, lin-
early increasing to 15% B in 6 min and held at 15% B for 10 min, linearly in-
creasing to 95% B in 8 min, held at 95% mobile phase B for 6 min, and 
finally back to 5% B in 2 min. 1-min eluates were collected into glass vials 
and subfractions were stored at 20°C until use.
LC-(ESI)-Q-Tof mass spectrometry analysis of thin layer chroma-
tography extracts. A universal normal phase HPLC-MS method for rapid 
separation of mycobacterial lipid classes (Layre et al., 2011) was modified 
to analyze mycobacterial antigens. In brief, TLC bands 3 and 4 were dried 
under gas nitrogen and were resuspended at 2 mg/ml in solvent A (hexane/ 
isopropanol 70:30 vol/vol, 0.02% formic acid, 0.01% ammonium hydrox-
ide). Electrospray mass spectrometry (6520 Accurate-Mass Q-Tof; Agilent 
Technologies) analyses were performed coupled with HPLC (1200 HPLC0; 
Agilent Technologies) using a 3 µm × 150 mm × 2 mm diol column (Varian) 
encounter CD1c. In this scenario, the antigenic function of PM 
is more physiologically important, considered as a processed 
product of MPM rather than a de novo product of biosynthesis.
Aside from these biological considerations, detection of a 
processed epitope provides key practical information for map-
ping of natural epitopes and detecting ex vivo T cell response. 
Whereas prior attempts to load CD1c tetramers with MPM 
and detect T cells ex vivo have been unsuccessful, successful 
development of CD1c tetramers derives from the insight that 
PM is a processed product and a natural epitope. Also, a key 
study that previously detected polyclonal human responses to 
MPD (Moody et al., 2000) can now be reinterpreted as pos-
sibly involving a mixture of glycosylated and unglycosylated 
epitopes. Supporting this view, tetramers provide evidence 
that T cell clones captured with a CD1c-PM epitope also re-
spond to MPM when presented by DCs.
That lipids would function as antigens by simultaneously 
binding to CD1c and the TCR has been a leading candidate 
mechanism for recognition, based on analogy to MHC, CD1d, 
and CD1b. However, bacterial lipids also cause stimulation 
of T cells by up-regulating CD1c expression, secreting IL-12, 
or by TLR-mediated triggering of endogenous lipid pro-
duction (De Libero et al., 2005; Roura-Mir et al., 2005b; 
Brennan et al., 2011; Brigl et al., 2011). Each of these three 
scenarios represent alternate mechanisms whereby foreign 
lipids like PM lead to T cell activation by mechanisms that 
do not require the bacterial lipid to contact the TCR. Develop-
ment of CD1c tetramers demonstrates ternary TCR–antigen–
CD1c interaction and provides direct evidence for cognate 
recognition of a primary phosphate epitope. In addition, stain-
ing of polyclonal T cells with tetramers provides direct biophysi-
cal evidence for the existence of polyclonal CD1c-PM–reactive 
TCRs in the peripheral blood.
In contrast to peptide antigens for T cells, which can rap-
idly generate point mutations that can be selected for evasion 
in a single epidemic, lipid structures are stable over evolu-
tionary time. Although immutable, lipids are susceptible to loss 
by deletion of genes involved in their biosynthesis. Studies of 
pks12 and mycoketide-deficient M. tuberculosis and M. avium 
indicate that mycoketides promote infection (Sirakova et al., 
2003) and so cannot be readily jettisoned as a means of im-
mune evasion. Thus, T cell targeting and selective CD1 pre-
sentation of virulence-conferring lipids represents a plausible 
mechanism of host defense. Consistent with this hypothesis, 
mycoketides are selectively produced by infection-competent 
mycobacteria of medical importance like M. tuberculosis, Myco-
bacterium bovis, and M. avium, as contrasted with environmen-
tal saprophytes (Matsunaga et al., 2004). Lipid-loaded CD1c 
tetramers provide direct proof for lipid-reactive TCRs ex vivo 
in humans and represent a new approach for broadly probing 
CD1c-reactive T cell function in vivo during natural infections.
MATERIALS AND METHODS
Bacteria. M. tuberculosis H37Rv was provided by P. Brennan (Colorado 
State University, Fort Collins, CO). M. avium serovar 4 was provided by 
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Generation of soluble CD1c and multimerization. Biotinylated CD1c 
monomers were produced in lentivirus-transduced 293T cells by the National 
Institutes of Health Tetramer Core Facility (Emory University) and described 
in detail elsewhere (Kasmar et al., 2011). In brief, human -2-microglobulin 
and the extracellular domain of CD1c separated by a 2A-TaV peptide were 
cloned into the lentiviral expression vector pCMJJ4. The chains are followed 
by a C-terminal acidic or basic leucine zipper which stabilizes the complex. 
Purified monomers were enzymatically biotinylated at the BSP85 site of the 
CD1c heavy chain. Monomer purity and composition were confirmed by SDS-
PAGE, and biotinylation was confirmed by streptavidin bead pulldown assay. 
CD1c monomers were loaded with C32-PM or C32-MPM in phosphate-
buffered saline, pH 7.4, at a 50-fold molar excess of lipid to protein. Lipid-
protein suspension was incubated for 18–24 h at 37°C followed by multimerization 
with streptavidin-conjugated allophycocyanin or PE (Invitrogen).
Native isoelectric focusing gel shift. CD1c was expressed in Hi5 cells 
using the baculovirus expression system and purified as described earlier 
(Scharf et al., 2010). CD1c was treated with endoglycosidase F3 for 2 h at 
37°C, purified by MonoQ anion exchange chromatography (GE Healthcare), 
and used for loading experiment with MPM and analogues. Mycoketide an-
alogues were dissolved in HBS (10 mM Hepes, 150 mM NaCl, pH 7.2) by 
sonicating at 50°C for 15 min using an ultrasonic cleaner (Branson). Aliquots 
of CD1c were incubated at 37°C for 5 min, followed by addition of indi-
cated molar excess of mycoketide or HBS control overnight at 37°C. Next 
day samples were centrifuged at 4°C at 16,000 g for 10 min then loaded on 
a PhastGel IEF 3–9 (GE Healthcare).
 TCR construct and expression. The DN6 TCR was identified by 
PCR screening using human IMGT database primer sets, IPS000029 for 
TCR- chains and IPS000003 for TCR- chains. To construct the  
TCR of DN6, individual TCR- and - chains, including leader and con-
stant regions were PCR cloned from DN6 primary cell line using Phusion 
high fidelity polymerase (New England Biolabs, Inc.) with primers designed 
from IMGT reference sequences for TRAV36/DV7 and TRBV6-6. The 
viral P2A sequence was cloned between TCR chains and a single full-length 
TCR construct was synthesized for dual expression as previously described 
(Holst et al., 2006). Primers used were as follows, TRAV36/DV7 5-GC-
GCCAGAATTCACCATGATGAAGTGTCCACAGGCTTTACTA-3 
with reverse primer for P2A-TRAC 5-CTTCCACGTCTCCTGCTT-
GCTTTAACAGAGAGAAGTTCGTGGCTCCGGAGCCGCTGGAC-
CACAGCCGCA-3. Primer P2A-TRBV6-6 5-CTGTTAAAGCAAGC-
AGGAGACGTGGAAGAAAACCCCGGTCCCATGAGCATCAGC-
CTCCTGTGCT-3 was used with reverse primer TRBC 5-GCGTC-
GGCGGCCGCTCAGCCTCTGGAATCCTTTCTCTTGAC-3. The 
products generated were used as template and amplified to a full-length 
TCR construct using forward primer TRAV36/DV7 primer with reverse 
primer TRBC. The partial sequence of the TRAV36/DV7 with CDR3 
junctional region is 5…CATCCTGAACATCACAGCCACCCAG-
ACCGGAGACTCGGCCGTCTACCTCTGTGCTTGGGCTGGTGG-
TACTAGCTATGGAAAGCTGACATTTGGACAAGGGACCATCTT-
GACTGTCCATCCA…3 and TRBV6-6 with CDR3 junctional region 
is 5…CTCCCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGG-
CATGGACTAGCTTCCTACGAGCAGTACTTCGGGCCGGGCAC-
CAGGCTCACGGTCACAG…3. For retroviral expression, the full-length 
TCR product was directionally cloned into a modified Mo-MLV retroviral 
vector (pMx) containing a puromycin resistance cassette and the retrovirus 
were packaged in 293T cells (Huang et al., 2011). Supernatant-containing 
virus was used to infect human lymphoblast cell lines SUP-T1 (CRL-1942, 
ATCC) and HuT78 (TIB-161, ATCC) and selected for puromycin resis-
tance and TCR expression with PM-loaded CD1c tetramers.
Tetramer staining and flow cytometry. DN6 and TCR expressing cell 
lines were stained with allophycocyanin-labeled or PE-labeled tetramer at 
10 µg/ml in PBS containing 0.5% BSA (FACS buffer) for 45 min at room 
temperature in the dark and subsequently stained with FITC anti-TCR V 
as previously described (Layre et al., 2011). Spectra were collected in nega-
tive mode from 100 to 3,000 m/z at 1 spectra/s and parent ions where col-
lided at 40 V to obtain collision products. Internal calibrations were 
performed using at calibrants at 121.050873 m/z and 922.009798 m/z that 
were coinfused into the spray chamber. Data were analyzed using Mass-
Hunter Workstation Qualitative Analysis Software (Agilent Technologies).
APCs, cell lines, and cellular assays. CD1+ MDDCs were prepared 
from human PBMC as previously described (Porcelli et al., 1992; Grant 
et al., 1999). In brief, PBMCs were collected from buffy coats by centrif-
ugation over Histopaque-1077 (Sigma-Aldrich), and monocytes were en-
riched with plastic adherence and cultured in RPMI-1640 supplemented 
with 10% FCS, Hepes, l-glutamine, essential and nonessential amino acids, 
sodium pyruvate, -mercaptoethanol, and penicillin/streptomycin (TCM) 
with 300 IU/ml GM-CSF and 200 IU/ml IL-4 for 3–5 d, followed by 
-irradiation (5,000 rad). The generation of K562 expressing CD1c were 
previously described (de Jong et al., 2010). Primary B cells were enriched 
from PBMC using human B cell Isolation kit II (Miltenyi Biotec) and stimu-
lated for 48 h with 20 µg/ml goat anti–human IgG F(ab)2 (Jackson Immuno-
Research Laboratories). DN6 and CD8-1 CD1c-restricted T cell lines 
were derived as previously described (Beckman et al., 1996; Grant et al., 
1999). In brief, enriched CD4CD8 (DN6) or CD8+ (CD8-1)  T cells 
and autologous CD1+ MDDC were cultured in complete media in the pres-
ence of a chloroform/methanol extract of Mycobacterium tuberculosis. T cell 
lines were restimulated every 2 wk with CD1+ DC and chloroform/methanol 
extract of Mycobacterium tuberculosis, followed by addition of recombinant 
human IL-2 after 3 d. For ex vivo analysis and cloning of CD1c tetramer+ 
cells, PBMCs were collected after informed consent from leukapheresis 
of asymptomatic tuberculin-positive subjects overseen by the institutional 
review boards of the Lemuel Shattuck Hospital (00000786) and Partners 
Healthcare (2002-P-000061) and the Harvard Committee on Microbio-
logic Safety (08–184). PBMCs were separated by Ficoll density gradient 
centrifugation and enriched for T cells using Dynabeads Untouched Human 
T Cells negative selection kit (Invitrogen). After resting overnight, T cells were 
stained with C32-PM loaded CD1c tetramers and sorted using FACSAria 
flow cytometer. C32-PM CD1c tetramer binding cells were expanded poly-
clonally or cloned by limiting dilution in the presence of an expansion mix-
ture, consisting of irradiated PBMC, EBV-transformed B cells, and 50 ng/ml 
anti-CD3 (clone OKT3). After an initial round of expansion, cells cloned 
by limiting dilution were screened for C32-PM CD1c tetramer binding with 
polyclonally expanded T cells resorted for C32-PM CD1c tetramer bind-
ing. All expanded lines were restimulated every other week with either 
expansion mixture or with Human T-activator CD3/CD28 Expansion 
and Activation beads (Invitrogen). Expanded C32-PM CD1c tetramer 
binding cells were assayed for bioactive IL-2 release or IFN- ELiSpot as 
described below at 30 and 80 d after T cell sort. 5 × 104 T cells were cultured 
with 5 × 104 CD1+ APCs in 96-well culture plates (0.2 ml/well) with titrat-
ing concentrations of synthetic lipid or lipidic extracts for 24 h (37°C, 5% 
CO2). In some experiments CD1 blocking antibody, anti-CD1a (OKT-6), 
anti-CD1b (bCD1b.3), anti-CD1c (F10.21A3), anti-CD1d (CD1d42), or 
IgG1 (P3) isotype was added to MDDC for 30 min before addition of 
T cells. For APC-free assays, recombinant CD1c was bound to streptavi-
din-coated 96-well plates (Thermo Scientific) at 10 µg/ml overnight at room 
temperature. The following day, titrating concentrations of lipid antigen 
in PBS were loaded onto CD1c by incubating for 24 h (37°C, 5% CO2). 
After antigen loading, plates were washed, and 105 DN6 or CD8-1 was 
added. To measure bioactive IL-2 release, 50 µl of spent supernatant was 
added to wells containing 100 µl media and 104 IL-2–dependent HT-2 cells 
to measure bioactive IL-2 release. After 24 h of culture, plates were pulsed with 
1 µCi 3H-thymidine for an additional 6 h before harvest (Filtermate har-
vester, Perkin Elmer) and  emission counting (Microbeta Trilux, Perkin 
Elmer). To measure IFN- release, T cells were stimulated in the presence 
of 15 µM of antigen presented by 2.5 × 104 CD1c expressing APC in 
Multiscreen IP plates (Millipore), and IFN- release was detected using 
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